CLINICAL STUDY: PRIMARY PULMONARY HYPERTENSION
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension
Ronald J. Raymond, MD*,
Alan L. Hinderliter, MD*,*,
Park W. Willis, IV, MD*,
David Ralph, MD ,
Edgar J. Caldwell, MD ,
William Williams, MD,
Neil A. Ettinger, MD ,
Nicholas S. Hill, MD||,
Warren R. Summer, MD¶,
Bennett de Boisblanc, MD¶,
Todd Schwartz, MS#,
Gary Koch, PhD#,
Linda M. Clayton, Pharm D**,
Maria M. Jöbsis, BA**,
James W. Crow, PhD,
Walker Long, MD Primary Pulmonary Hypertension Study Group
* University of North Carolina, Chapel Hill, North Carolina, USA
University of Washington, Seattle, Washington, USA
Maine Medical Center, Portland, Maine, USA
Washington University, St. Louis, Missouri, USA
|| Rhode Island Hospital, Providence, Rhode Island, USA
¶ Louisiana State University Medical Center, New Orleans, Louisana, USA
# Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA
** GlaxoWellcome Inc., Research Triangle Park, North Carolina, USA
United Therapeutics, Inc., Chapel Hill, North Carolina, USA
Cato Research Ltd., Durham, North Carolina, USA
Manuscript received August 8, 2001;
revised manuscript received January 3, 2002,
accepted January 16, 2002.
* Reprint requests and correspondence: Dr. Alan L. Hinderliter, Division of Cardiology, University of North Carolina, CB # 7075, 338 Burnett-Womack, Chapel Hill, North Carolina 27599-7075, USA
hinderli{at}med.unc.edu
OBJECTIVES: The aim of this study was to evaluate the relationships between echocardiographic findings and clinical outcomes in patients with severe primary pulmonary hypertension (PPH).
BACKGROUND: Primary pulmonary hypertension is associated with abnormalities of right heart structure and function that contribute to the poor prognosis of the disease. Echocardiographic abnormalities associated with PPH have been described, but the prognostic significance of these findings remains poorly characterized.
METHODS: Echocardiographic studies, invasive hemodynamic measurements and 6-min walk tests were performed and outcomes prospectively followed in 81 patients with severe PPH. Subjects were participants in a 12-week randomized trial examining the effects of prostacyclin plus conventional therapy compared with conventional therapy alone.
RESULTS: During the mean follow-up period of 36.9 ± 15.4 months, 20 patients died and 21 patients underwent transplantation. Pericardial effusion (p = 0.003) and indexed right atrial area (p = 0.005) were predictors of mortality. Pericardial effusion (p = 0.017), indexed right atrial area (p = 0.012) and the degree of septal shift in diastole (p = 0.004) were predictors of a composite end point of death or transplantation. In multivariable analyses incorporating clinical, hemodynamic and echocardiographic variables, pericardial effusion and an enlarged right atrium remained predictors of adverse outcomes. Six-minute walk results, mixed venous oxygen saturation and initial treatment randomization were also independently associated with a poor prognosis.
CONCLUSIONS: Pericardial effusion, right atrial enlargement and septal displacement are echocardiographic abnormalities that reflect the severity of right heart failure and predict adverse outcomes in patients with severe PPH. These characteristics may help identify patients appropriate for more intensive medical therapy or earlier transplantation.
|
Abbreviations and Acronyms
| | CI | | confidence interval | | HR | | hazard ratio | | NYHA | | New York Heart Association | | PPH | | primary pulmonary hypertension | | RA | | right atrium | | RVEDA | | right ventricular end-diastolic area | | RVESA | | right ventricular end-systolic area | | TR | | tricuspid regurgitation |
|
This article has been cited by other articles:
|
|
|
|
 
A. J. Peacock, R. Naeije, N. Galie, and L. Rubin
End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?
Eur. Respir. J.,
July 1, 2009;
34(1):
231 - 242.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. B. Badesch, H. C. Champion, M. A. Gomez Sanchez, M. M. Hoeper, J. E. Loyd, A. Manes, M. McGoon, R. Naeije, H. Olschewski, R. J. Oudiz, et al.
Diagnosis and assessment of pulmonary arterial hypertension.
J. Am. Coll. Cardiol.,
June 30, 2009;
54(1 Suppl):
S55 - S66.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Puwanant, T. C. Priester, F. Mookadam, C. J. Bruce, M. M. Redfield, and K. Chandrasekaran
Right ventricular function in patients with preserved and reduced ejection fraction heart failure
Eur J Echocardiogr,
May 13, 2009;
(2009)
jep052v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Fisher, P. R. Forfia, E. Chamera, T. Housten-Harris, H. C. Champion, R. E. Girgis, M. C. Corretti, and P. M. Hassoun
Accuracy of Doppler Echocardiography in the Hemodynamic Assessment of Pulmonary Hypertension
Am. J. Respir. Crit. Care Med.,
April 1, 2009;
179(7):
615 - 621.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. PAMIDI and S. MEHTA
Six-Minute Walk Test in Scleroderma-Associated Pulmonary Arterial Hypertension: Are We Counting What Counts?
J Rheumatol,
February 1, 2009;
36(2):
216 - 218.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Cho, P. Jiamsripong, A. M. Calleja, M. S. Alharthi, E. M. McMahon, B. K. Khandheria, and M. Belohlavek
Right ventricular free wall circumferential strain reflects graded elevation in acute right ventricular afterload
Am J Physiol Heart Circ Physiol,
February 1, 2009;
296(2):
H413 - H420.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Castaner, X. Gallardo, E. Ballesteros, M. Andreu, Y. Pallardo, J. M. Mata, and L. Riera
CT Diagnosis of Chronic Pulmonary Thromboembolism
RadioGraphics,
January 1, 2009;
29(1):
31 - 50.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. E. Ventetuolo, R. L. Benza, A. J. Peacock, R. T. Zamanian, D. B. Badesch, and S. M. Kawut
Surrogate and Combined End Points in Pulmonary Arterial Hypertension
Proceedings of the ATS,
July 15, 2008;
5(5):
617 - 622.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Avouac, J Wipff, A Kahan, and Y Allanore
Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials
Ann Rheum Dis,
June 1, 2008;
67(6):
808 - 814.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. M. Chin and L. J. Rubin
Pulmonary arterial hypertension.
J. Am. Coll. Cardiol.,
April 22, 2008;
51(16):
1527 - 1538.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Haddad, R. Doyle, D. J. Murphy, and S. A. Hunt
Right Ventricular Function in Cardiovascular Disease, Part II: Pathophysiology, Clinical Importance, and Management of Right Ventricular Failure
Circulation,
April 1, 2008;
117(13):
1717 - 1731.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Lopez-Candales, K Dohi, N Rajagopalan, K Edelman, B Gulyasy, and R Bazaz
Defining normal variables of right ventricular size and function in pulmonary hypertension: an echocardiographic study
Postgrad. Med. J.,
January 1, 2008;
84(987):
40 - 45.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Mason, D. H. Marsh, J. M. Alster, S. C. Murthy, A. M. McNeill, M. M. Budev, A. C. Mehta, G. B. Pettersson, and E. H. Blackstone
Atrial Fibrillation After Lung Transplantation: Timing, Risk Factors, and Treatment
Ann. Thorac. Surg.,
December 1, 2007;
84(6):
1878 - 1884.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.G. Coghlan and J. Davar
How should we assess right ventricular function in 2008?
Eur. Heart J. Suppl.,
December 1, 2007;
9(suppl_H):
H22 - H28.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G.-P. Diller, K. Dimopoulos, H. Kafka, S. Y. Ho, and M. A. Gatzoulis
Model of chronic adaptation: right ventricular function in Eisenmenger syndrome
Eur. Heart J. Suppl.,
December 1, 2007;
9(suppl_H):
H54 - H60.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Galie, A. Manes, M. Palazzini, L. Negro, S. Romanazzi, and A. Branzi
Pharmacological impact on right ventricular remodelling in pulmonary arterial hypertension
Eur. Heart J. Suppl.,
December 1, 2007;
9(suppl_H):
H68 - H74.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Bapoje, J. F. Whitaker, T. Schulz, E. S. Chu, and R. K. Albert
Preoperative Evaluation of the Patient With Pulmonary Disease
Chest,
November 1, 2007;
132(5):
1637 - 1645.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Cioffi, G. de Simone, G. Mureddu, L. Tarantini, and C. Stefenelli
Right atrial size and function in patients with pulmonary hypertension associated with disorders of respiratory system or hypoxemia
Eur J Echocardiogr,
October 1, 2007;
8(5):
322 - 331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. van Wolferen, J. T. Marcus, A. Boonstra, K. M.J. Marques, J. G.F. Bronzwaer, M. D. Spreeuwenberg, P. E. Postmus, and A. Vonk-Noordegraaf
Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension
Eur. Heart J.,
May 2, 2007;
28(10):
1250 - 1257.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Taylor, G. Derrick, A. McEwan, S. G. Haworth, and M. R. J. Sury
Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension
Br. J. Anaesth.,
May 1, 2007;
98(5):
657 - 661.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Fischer, S. Misumi, D. Curran-Everett, R. T. Meehan, S. K. Ulrich, J. J. Swigris, S. K. Frankel, G. P. Cosgrove, D. A. Lynch, and K. K. Brown
Pericardial Abnormalities Predict the Presence of Echocardiographically Defined Pulmonary Arterial Hypertension in Systemic Sclerosis-Related Interstitial Lung Disease
Chest,
April 1, 2007;
131(4):
988 - 992.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. P. McCann, C. T. Gan, A. M. Beek, H. W. M. Niessen, A. V. Noordegraaf, and A. C. van Rossum
Extent of MRI Delayed Enhancement of Myocardial Mass Is Related to Right Ventricular Dysfunction in Pulmonary Artery Hypertension
Am. J. Roentgenol.,
February 1, 2007;
188(2):
349 - 355.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. A. Minai, C. M. Pandya, J. A. Golish, J. F. Avecillas, K. McCarthy, S. Marlow, and A. C. Arroliga
Predictors of Nocturnal Oxygen Desaturation in Pulmonary Arterial Hypertension
Chest,
January 1, 2007;
131(1):
109 - 117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. T. Gan, G. P. McCann, J. T. Marcus, S. A. van Wolferen, J. W. Twisk, A. Boonstra, P. E. Postmus, and A. Vonk-Noordegraaf
NT-proBNP reflects right ventricular structure and function in pulmonary hypertension
Eur. Respir. J.,
December 1, 2006;
28(6):
1190 - 1194.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. R. Forfia, M. R. Fisher, S. C. Mathai, T. Housten-Harris, A. R. Hemnes, B. A. Borlaug, E. Chamera, M. C. Corretti, H. C. Champion, T. P. Abraham, et al.
Tricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension
Am. J. Respir. Crit. Care Med.,
November 1, 2006;
174(9):
1034 - 1041.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. F. Voelkel, R. A. Quaife, L. A. Leinwand, R. J. Barst, M. D. McGoon, D. R. Meldrum, J. Dupuis, C. S. Long, L. J. Rubin, F. W. Smart, et al.
Right Ventricular Function and Failure: Report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure
Circulation,
October 24, 2006;
114(17):
1883 - 1891.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Fischer, R. T. Meehan, C. A. Feghali-Bostwick, S. G. West, and K. K. Brown
Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease.
Chest,
October 1, 2006;
130(4):
976 - 981.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Fijalkowska, M. Kurzyna, A. Torbicki, G. Szewczyk, M. Florczyk, P. Pruszczyk, and M. Szturmowicz
Serum N-Terminal Brain Natriuretic Peptide as a Prognostic Parameter in Patients With Pulmonary Hypertension
Chest,
May 1, 2006;
129(5):
1313 - 1321.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Mahapatra, R. A. Nishimura, P. Sorajja, S. Cha, and M. D. McGoon
Relationship of Pulmonary Arterial Capacitance and Mortality in Idiopathic Pulmonary Arterial Hypertension
J. Am. Coll. Cardiol.,
February 21, 2006;
47(4):
799 - 803.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Rubin
Pulmonary arterial hypertension.
Proceedings of the ATS,
January 1, 2006;
3(1):
111 - 115.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Ramakrishna, J. Sprung, B. S. Ravi, K. Chandrasekaran, and M. D. McGoon
Impact of Pulmonary Hypertension on the Outcomes of Noncardiac Surgery: Predictors of Perioperative Morbidity and Mortality
J. Am. Coll. Cardiol.,
May 17, 2005;
45(10):
1691 - 1699.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Bossone, B. D. Bodini, A. Mazza, and L. Allegra
Pulmonary Arterial Hypertension: The Key Role of Echocardiography
Chest,
May 1, 2005;
127(5):
1836 - 1843.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Task Force members, N. Galie, A. Torbicki, R. Barst, P. Dartevelle, S. Haworth, T. Higenbottam, H. Olschewski, A. Peacock, G. Pietra, et al.
Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology
Eur. Heart J.,
December 2, 2004;
25(24):
2243 - 2278.
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Sitbon, V. Gressin, R. Speich, P. S. Macdonald, M. Opravil, D. A. Cooper, T. Fourme, M. Humbert, J.-F. Delfraissy, and G. Simonneau
Bosentan for the Treatment of Human Immunodeficiency Virus-associated Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med.,
December 1, 2004;
170(11):
1212 - 1217.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Campana, M. Pasotti, L. Monti, M. Revera, A. Serio, L. Nespoli, G. Magrini, L. Scelsi, S. Ghio, and L. Tavazzi
The evaluation of right ventricular performance in different clinical models of heart failure
Eur. Heart J. Suppl.,
November 1, 2004;
6(suppl_F):
F61 - F67.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. V. McLaughlin, K. W. Presberg, R. L. Doyle, S. H. Abman, D. C. McCrory, T. Fortin, and G. Ahearn
Prognosis of Pulmonary Arterial Hypertension*: ACCP Evidence-Based Clinical Practice Guidelines
Chest,
July 1, 2004;
126(1_suppl):
78S - 92S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Hoeper, R. J. Oudiz, A. Peacock, V. F. Tapson, S. G. Haworth, A. E. Frost, and A. Torbicki
End points and clinical trial designs in pulmonary arterial hypertension: Clinical and regulatory perspectives
J. Am. Coll. Cardiol.,
June 16, 2004;
43(12_Suppl_S):
48S - 55S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. S. Klings, H. W. Farber, P. M. Hassoun, J. A. Krishnan, M. T. Gladwin, V. Sachdev, and F. P. Ognibene
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
N. Engl. J. Med.,
June 10, 2004;
350(24):
2521 - 2522.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Peacock, R. Naeije, N. Galie, and J.T. Reeves
End points in pulmonary arterial hypertension: the way forward
Eur. Respir. J.,
June 1, 2004;
23(6):
947 - 953.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Torbicki, M. Kurzyna, P. Kuca, A. Fijalkowska, J. Sikora, M. Florczyk, P. Pruszczyk, J. Burakowski, and L. Wawrzynska
Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension
Circulation,
August 19, 2003;
108(7):
844 - 848.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Galie, A. L. Hinderliter, A. Torbicki, T. Fourme, G. Simonneau, T. Pulido, N. Espinola-Zavaleta, G. Rocchi, A. Manes, R. Frantz, et al.
Effects of the oral endothelin-receptorantagonist bosentan on echocardiographicand doppler measures in patients with pulmonary arterial hypertension
J. Am. Coll. Cardiol.,
April 16, 2003;
41(8):
1380 - 1386.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Chemla, V. Castelain, P. Herve, Y. Lecarpentier, and S. Brimioulle
Haemodynamic evaluation of pulmonary hypertension
Eur. Respir. J.,
November 1, 2002;
20(5):
1314 - 1331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
